• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清HE4和CA125浓度对子宫内膜癌淋巴转移的预测价值。

Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.

作者信息

Wang Yingmei, Han Cha, Teng Fei, Bai Zhaoyi, Tian Wenyan, Xue Fengxia

机构信息

Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.

出版信息

Int J Gynaecol Obstet. 2017 Jan;136(1):58-63. doi: 10.1002/ijgo.12010. Epub 2016 Nov 3.

DOI:10.1002/ijgo.12010
PMID:28099710
Abstract

OBJECTIVE

To evaluate the predictive value of serum HE4 and CA125 concentrations in the preoperative prediction of risk of lymph node metastasis in endometrial cancer.

METHODS

A retrospective study was undertaken of data for patients with endometrial carcinoma treated surgically at a university hospital in China between August 2011 and December 2015. The preoperative serum levels of HE4 and CA125 were measured and analyzed by clinicopathologic characteristics.

RESULTS

Overall, 258 patients were included. The HE4 and CA125 concentrations were significantly elevated in patients with large lesions (≥2 cm), deep myometrial invasion (≥50%), an advanced disease stage, or lymph node metastasis (P<0.05 for all). HE4 concentrations also rose with age and histologic grade (P<0.01 for both). For lymph node metastasis, HE4 had higher sensitivity and negative predictive value than did CA125. The diagnostic performance of HE4 and CA125 in combination was superior to that of either marker alone.

CONCLUSION

The combined evaluation of serum HE4 and CA125 could provide gynecologic oncologists with improved information to guide the decision of whether to perform lymphadenectomy.

摘要

目的

评估血清HE4和CA125浓度在子宫内膜癌术前预测淋巴结转移风险中的预测价值。

方法

对2011年8月至2015年12月在中国某大学医院接受手术治疗的子宫内膜癌患者的数据进行回顾性研究。通过临床病理特征对术前血清HE4和CA125水平进行测量和分析。

结果

共纳入258例患者。在病变较大(≥2 cm)、肌层浸润较深(≥50%)、疾病分期较晚或有淋巴结转移的患者中,HE4和CA125浓度显著升高(所有P<0.05)。HE4浓度也随年龄和组织学分级升高(两者P均<0.01)。对于淋巴结转移,HE4的敏感性和阴性预测值高于CA125。HE4和CA125联合检测的诊断效能优于单一标志物。

结论

血清HE4和CA125联合评估可为妇科肿瘤学家提供更多信息,以指导是否进行淋巴结清扫术的决策。

相似文献

1
Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.血清HE4和CA125浓度对子宫内膜癌淋巴转移的预测价值。
Int J Gynaecol Obstet. 2017 Jan;136(1):58-63. doi: 10.1002/ijgo.12010. Epub 2016 Nov 3.
2
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.HE4 和 CA125 作为子宫内膜样腺癌术前淋巴结转移的风险分层因子:一项具有淋巴结状态组织学证据的队列回顾性研究。
Gynecol Oncol. 2021 Feb;160(2):514-519. doi: 10.1016/j.ygyno.2020.11.004. Epub 2020 Nov 16.
3
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).HE4 和 CA125 水平在子宫内膜癌患者术前评估中的应用:一项前瞻性多中心研究(ENDOMET)。
Acta Obstet Gynecol Scand. 2013 Nov;92(11):1313-22. doi: 10.1111/aogs.12235.
4
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.在高危子宫内膜癌患者复发性疾病的检测中,人附睾蛋白4(HE4)优于癌抗原125(CA125)。
Tumour Biol. 2018 Feb;40(2):1010428318757103. doi: 10.1177/1010428318757103.
5
Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.血清人附睾蛋白 4 和癌抗原 125 浓度在子宫内膜癌中的预测价值。
Am J Obstet Gynecol. 2013 Aug;209(2):142.e1-6. doi: 10.1016/j.ajog.2013.04.014. Epub 2013 Apr 10.
6
Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.HE4用于识别可能需要进行淋巴结切除术的子宫内膜样子宫内膜癌患者的效用。
Adv Med Sci. 2016 Mar;61(1):23-7. doi: 10.1016/j.advms.2015.07.010. Epub 2015 Aug 9.
7
The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.术前血清CA125联合HE4预测子宫内膜癌淋巴结转移的效用
Gynecol Obstet Invest. 2023;88(1):53-60. doi: 10.1159/000528851. Epub 2023 Jan 3.
8
Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.术前血清CA125水平对子宫内膜癌患者预后预测的价值。
Aust N Z J Obstet Gynaecol. 2011 Oct;51(5):397-402. doi: 10.1111/j.1479-828X.2011.01325.x. Epub 2011 Jun 9.
9
Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.术前了解生物标志物人附睾蛋白4在早期子宫内膜癌手术治疗中的重要性。
Anticancer Res. 2017 May;37(5):2697-2702. doi: 10.21873/anticanres.11619.
10
Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy.术前盆腔磁共振成像及血清癌抗原125:筛选1级子宫内膜癌患者进行淋巴结清扫术
AJR Am J Roentgenol. 2015 Nov;205(5):W556-64. doi: 10.2214/AJR.14.13746.

引用本文的文献

1
Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma.血清CA125和HE4水平作为预测子宫内膜癌区域淋巴结转移的工具
Cancers (Basel). 2025 Aug 23;17(17):2740. doi: 10.3390/cancers17172740.
2
Tumor biomarkers HE4 and CA125 alongside enhanced computed tomography imaging in assessing lymph node metastasis in endometrial cancer.肿瘤生物标志物HE4和CA125联合增强计算机断层扫描成像在评估子宫内膜癌淋巴结转移中的应用
Bioinformation. 2024 Nov 30;20(11):1453-1460. doi: 10.6026/9732063002001453. eCollection 2024.
3
Relationship between HE4 levels and metabolic parameters in PET of non-small cell lung cancer patients.
非小细胞肺癌患者正电子发射断层显像中HE4水平与代谢参数的关系
Biomark Med. 2025 Apr;19(7):259-265. doi: 10.1080/17520363.2025.2471744. Epub 2025 Mar 1.
4
Evaluating pretreatment serum CA-125 levels as prognostic biomarkers in endometrial cancer: a comprehensive meta-analysis.评估术前血清CA-125水平作为子宫内膜癌的预后生物标志物:一项全面的荟萃分析。
Front Oncol. 2024 Sep 27;14:1442814. doi: 10.3389/fonc.2024.1442814. eCollection 2024.
5
Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.预测子宫内膜癌淋巴结转移的模型:系统评价和文献计量分析。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241248398. doi: 10.1177/17455057241248398.
6
Clinical Significance of Lymphatic Infiltration Detected by Immunohistochemical Double Staining in Patients with Endometrial Cancer.免疫组织化学双重染色检测子宫内膜癌患者淋巴管浸润的临床意义
Clin Med Insights Oncol. 2023 Feb 1;17:11795549231152308. doi: 10.1177/11795549231152308. eCollection 2023.
7
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features.血清CA125和HE4作为检测子宫内膜癌及相关高危特征的生物标志物。
Diagnostics (Basel). 2022 Nov 17;12(11):2834. doi: 10.3390/diagnostics12112834.
8
Nomograms Based on Fibrinogen, Albumin, Neutrophil-Lymphocyte Ratio, and Carbohydrate Antigen 125 for Predicting Endometrial Cancer Prognosis.基于纤维蛋白原、白蛋白、中性粒细胞与淋巴细胞比值及糖类抗原125预测子宫内膜癌预后的列线图
Cancers (Basel). 2022 Nov 16;14(22):5632. doi: 10.3390/cancers14225632.
9
Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.血清 HE4 和 CA125 联合预测和监测 II 型子宫内膜癌的复发。
Sci Rep. 2021 Nov 4;11(1):21694. doi: 10.1038/s41598-021-01263-w.
10
HE4 as a Biomarker for Endometrial Cancer.人附睾蛋白4作为子宫内膜癌的生物标志物
Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764.